Delai Chen

Company: Beam Therapeutics Inc.

Job title: Director - Nanoparticle Formulation

Seminars:

Panel Discussion: ‘Evaluating LVV & LNP Delivery Method Clinical Potential in In Vivo Cell & Gene Therapies 2:00 pm

Discussing the long-term efficacy and durability of LVV and LNP-based therapies to understand the impact of delivery on disease regression and treatment Exploring how LVV, LNP and RNP technologies can evolve to produce enhanced therapeutic outcomes Evaluating the potential of the delivery vehicles to deliver complex payloadsRead more

day: Day Two